Clin2
NCT07084662Possibly a fitRecruiting

Xinlikang capsule for fatigue after lymphoma treatment

Diffuse Large B-Cell Lymphoma (DLBCL)

Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.

This trial tests a Chinese herbal capsule, Xinlikang, to see if it helps reduce fatigue and improve immune function after chemotherapy for diffuse large B-cell lymphoma. It is for people who have finished their first treatment and still feel very tired.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older.
  • You have been newly diagnosed with diffuse large B-cell lymphoma (DLBCL) and have completed your first round of chemotherapy and immunotherapy.
  • You have significant fatigue (rated 4 or more on a 0-10 scale) after finishing treatment.
  • You are not planning to receive other cancer treatments (like radiation, chemo, or other drugs) for the next 3 months.
  • You do not have serious liver, kidney, or bone marrow problems, active infections, or other cancers.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06739720Recruiting· Phase 2/Phase 3
Test of CP003 for chronic fatigue or long COVID tiredness

This study tests a new supplement called CP003 to see if it helps reduce tiredness in people with chronic fatigue syndrome or long COVID fatigue.

Hong Kong
NCT06823895Recruiting· Phase 1
Study of Maixuekang capsules in healthy volunteers

This trial studies how Maixuekang capsules are processed in the body of healthy adults. It looks at the drug's levels over time to make sure it works safely.

Guangzhou
NCT07818499Not yet recruiting· Phase 1/Phase 2
New drug with chemotherapy and immunotherapy for lymphoma

This study tests a new drug combined with standard chemotherapy and immune therapy for people with diffuse large B-cell lymphoma. The goal is to see if the combination is safe and helps shrink or control the cancer.

Guangzhou, Guangdong
NCT06381557Not yet recruiting· Phase 4
Zhengyuan capsules for cancer fatigue after breast cancer treatment

This trial tests a traditional Chinese medicine called Zhengyuan capsules to see if it helps relieve cancer-related fatigue in women who have finished their main breast cancer treatment. If you're still feeling very tired after treatment, this study might offer a new way to improve your energy.

NCT06047626Recruiting
Living well with lymphoma: a fatigue and nutrition study

This study tests if eating more fruits and vegetables can help reduce persistent fatigue in people with lymphoma. You will receive questionnaires by email to track your fatigue and diet over time.

Ann Arbor, Michigan
NCT06807515Enrolling by invitation
Safety study of FL Nourish supplement for cancer survivors in remission

This study is testing whether a natural herbal supplement called FL Nourish Capsules is safe for people who have had cancer and are now in remission. It focuses on those with a Traditional Chinese Medicine pattern of Qi deficiency and Blood stasis, which may cause tiredness and poor circulation.

Singapore, SG

Hear when a new Diffuse Large B-Cell Lymphoma (DLBCL) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.